openPR Logo
Press release

Global Antibody Drug Conjugate Market Size, Share and Trends Analysis Report, By Drugs (Adcetris, Kadcyla), By Mechanism of Action (CD30 Antibodies, HER2 Antibodies), and By Application (Breast Cancer, Lymphoma) Forecast (2022-2028)

03-24-2022 02:42 PM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Orion Market Reports

The global antibody drug conjugate market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). The increasing geriatric population, rising prevalence of various types of cancer , and increased government investments in pharmaceutical research and development activities for more advanced cancer drugs and therapeutics are the key factors driving the global antibody drug conjugate market. More than 100 clinical trials for ADCs are currently underway. Companies are requesting label expansion for currently approved products. For instance, in Jan 2021, Enhertu, which was previously approved for breast cancer, has now been approved in the United States for the treatment of locally advanced or metastatic HER2-positive gastric cancer.

A full report of Wooden Decking Market is available at:https://orionmarketreports.com/global-antibody-drug-conjugate-market/92810/  

Increased R&D activities are expected to fuel the growth of the global antibody-drugdrug conjugates market. For instance, in December 2020, ADC Therapeutics SA, a late-stage biotechnology company focused on oncology, announced the latest clinical data from its two leading projects, Loncastuximab-Tesirine (Lonca) and Camidanlumab-Tesirine (Cami), at the 62nd yearly session of the American Culture of Hematology (ASH) 2020. LoncastuximabTesirine is an antibody-drug conjugate (ADC) composed of a humanized monoclonal antibody directed against human Cluster of Differentiation (CD)19 and conjugated to a pyrrolobenzodiazepine (PBD) dimeric cytotoxin via a linker. CamidanlumabTesirin is an antibody drug conjugate (ADC) composed of a monoclonal antibody that binds to CD25 and is conjugated to the pyrrolobenzodiazepine (PBD) dimer payload tesirin.

Looking towards the high demand for antibody-drug conjugate key manufacturers of the antibody-drug conjugate are adopting several market growth strategies such as mergers & acquisitions, partnerships, and new product launches among others to meet the growing demand for dental biomaterials of dental consumables.For instance, in October 2020 Gilead completed its acquisition of Immunomedics, Inc. for approximately $ 21 billion. Gilead was able to gain access to Immunomedics' ADC portfolio as a result of this acquisition. At the time of the acquisition, Immunomedics already had one commercialized ADC product, Trodelvy, as well as multiple products in clinical trials.

Market Coverage

The market number available for - 2021-2028
Base year- 2021
Forecast period- 2022-2028
Segment Covered-
By Drugs
By Mechanism Of Action
By Application
Regions Covered-
North America
Europe
Asia-Pacific
Rest of the World
Competitive Landscape- F. Hoffman-La Roche Ltd., Novartis AG, Takeda Pharmaceutical Company Limited, Pfizer, Inc., Seattle Genetics Inc., among others.

Key questions addressed by the report

What is the market growth rate?
Which segment and region dominate the market in the base year?
Which segment and region will project the fastest growth in the market?
How has COVID-19 impacted the market?
Deviation from the pre-COVID-19 forecast
Most affected region and segment
Who is the leader in the market?
How players are addressing challenges to sustain growth?
Where is the investment opportunity?

Global Antibody Drug Conjugate Market Report by Segment

By Drugs

Adcetris
Kadcyla

By Mechanism of Action

CD30 Antibodies
HER2 Antibodies

By Application

Breast Cancer
Lymphoma

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Antibody Drug Conjugate Market Size, Share and Trends Analysis Report, By Drugs (Adcetris, Kadcyla), By Mechanism of Action (CD30 Antibodies, HER2 Antibodies), and By Application (Breast Cancer, Lymphoma) Forecast (2022-2028) here

News-ID: 2586270 • Views:

More Releases from Orion Market Reports

Module Power Supply Market to see Huge Growth by 2031
Module Power Supply Market to see Huge Growth by 2031
The Module Power Supply Market is experiencing substantial growth, fueled by increasing demand for efficient, compact, and reliable power solutions across a wide range of industries. These power supplies, which convert electrical power to a suitable form for specific applications, are essential in sectors like telecommunications, automotive, medical devices, and consumer electronics. With technological advancements and rising energy efficiency needs, the market is expected to continue expanding, driven by innovations
Plasma Spray Guns Market to see Rapid Growth by 2031
Plasma Spray Guns Market to see Rapid Growth by 2031
The Plasma Spray Guns Market is witnessing significant growth, driven by the rising demand for surface coating and thermal spray applications across industries such as aerospace, automotive, manufacturing, and electronics. Plasma spray guns are widely used for depositing coatings on substrates to enhance their properties, including wear resistance, corrosion resistance, and thermal protection. As industries continue to focus on improving product performance and durability, the plasma spray gun market is
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
Plasma Surface Treatment Machine Market Will Generate Record Revenue by 2031
The Plasma Surface Treatment Machine Market is witnessing significant growth as industries increasingly adopt plasma surface treatment technology for enhancing the properties of materials. Plasma surface treatment machines are used to modify the surface characteristics of materials like metals, plastics, and ceramics, offering improvements in adhesion, corrosion resistance, and wear resistance. As the demand for advanced surface treatments rises across automotive, electronics, packaging, and manufacturing sectors, the market for plasma
Plasma Torch Market Value Projected to Expand by 2031
Plasma Torch Market Value Projected to Expand by 2031
The Plasma Torch Market is experiencing rapid growth, driven by the increasing demand for high-precision cutting and welding technologies in industries such as manufacturing, automotive, aerospace, and construction. Plasma torches are essential tools in thermal cutting applications, offering fast and accurate cuts on various materials, including metals, plastics, and composites. With advancements in plasma cutting technology and the growing need for energy-efficient solutions, the market for plasma torches continues to

All 5 Releases


More Releases for ADC

ADC Market: Transforming Cancer Treatment
The global market for antibody-drug conjugates (ADCs) was valued at US$ 11.32 billion in 2023 and is expected to reach US$ 27.37 billion by 2033, growing at a compound annual growth rate (CAGR) of 9.23% from 2024 to 2033. This growth is primarily driven by the increasing prevalence of cancer and the growing demand for safe and effective treatments. Antibody Drug Conjugates: A Growing Force in Cancer Treatment and Market Expansion Key
With Knockout ADC Innovations, Creative Biolabs Took Center Stage at the 2024 Wo …
Creative Biolabs wrapped up a successful show at the 15th Annual World ADC San Diego in the beginning of November, where its third year of participation, highlighting its dedication to the advancement of antibody-drug conjugate (ADC) technology. New York, USA - November 13, 2024 - Creative Biolabs seized the spotlight at Booth 313 by offering groundbreaking solutions across the entire ADC development spectrum, which demonstrate their unrivaled expertise and dedication to
Showing Off Their ADC Game: Creative Biolabs Hits the 15th Annual World ADC Summ …
From November 4, Creative Biolabs will be back at the 15th Annual World ADC Summit in San Diego, marking its fourth year at the leading global gathering featuring innovative conjugates. New York, USA - November 6, 2024 - Creative Biolabs invites all ADC enthusiasts, from new entrants to seasoned experts, to explore its comprehensive suite of ADC solutions and experience the latest in antibody-drug conjugate (ADC) innovation at Booth #313. Image: https://www.getnews.info/uploads/0c59d26f78bf6dd58aafee5bc68d7d8c.jpg "2023
ADC Drugs For Breast Cancer Treatment
Breast cancer is the malignant tumor with the highest morbidity and mortality among women worldwide. At present, the main therapeutic methods include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy, etc. The development and marketing of new drugs have far-reaching significance in improving the survival of breast cancer patients and changing the pattern of breast cancer treatment. On February 24, 2023, The NMPA approved Enhertu, an injectable drug developed jointly by
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Succe …
Analog-to-Digital Converters Market by Product (Ramp ADC, Integrating ADC, Successive Approximation ADC, Delta-sigma ADC, and Others (Pipelined/Flash ADC)), and Application (Consumer Electronics and Industrial) - Global Opportunity Analysis and Industry Forecast, 2017-2023 Full Report : https://www.alliedmarketresearch.com/analog-to-digital-converters-market Increasing disposable income and technological advancements supplement the analog-to-digital converters market. However, complex design of the ADC hampers this market growth. On the other hand, encouragement in digitization of work processes by government in emerging economies,
Global Data Converters Market Report 2017 (Analog to Digital Converter, Current …
The research report titled Global Data Converters Sales Market Report 2017 market size and forecast and overview on current market trends. This report studies sales (consumption) of Global Data Converters Market 2017, especially in United States, China, Europe and Japan, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering National Semiconductor Nippon Precision Circuits Inc Micro Analog systems Microchip Technology. TelCom Semiconductor, Inc Vishay Siliconix Texas